Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration

SIZMAZ S., ESEN E., Isik-Ericek P., Demircan N.

CLINICAL AND EXPERIMENTAL OPTOMETRY, cilt.105, sa.1, ss.55-60, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1080/08164622.2021.1896334
  • Dergi Adı: CLINICAL AND EXPERIMENTAL OPTOMETRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.55-60
  • Anahtar Kelimeler: Aflibercept, central macular thickness, neovascular age-related macular degeneration, ranibizumab, subfoveal choroidal thickness
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: The aim of this study is to analyse the real-world outcome of vascular endothelial growth factor blocking agents in neovascular age-related macular degeneration.